Home › Squamous Cell Carcinoma › Texas › Houston
Squamous Cell Carcinoma clinical trials in Houston, TX
7 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Intratumoral N17350 in Advanced Solid Tumors
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site, Houston
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- MD Anderson Cancer Center, Houston
- Oncology Consultants, Houston
A Study of VET3-TGI in Patients With Solid Tumors
RecruitingPhase 1
- University of Texas MD Anderson Cancer Center, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- New York City, NY7 studies
- Nashville, TN7 studies
- Atlanta, GA5 studies
- Queens, NY4 studies
- Washington, DC4 studies
- Arlington, VA4 studies
- Orlando, FL4 studies
- Durham, NC4 studies
- Tampa, FL4 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.